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Cellular activation involves the re-organization of receptor molecules and the intracellular signalosom in the cell membrane. Recent studies
indicate that specialized domains of the cell membrane, termed rafts, are central for the spatial organization of receptors and signaling molecules.
Rafts are converted into larger membrane platforms by activity of the acid sphingomyelinase, which hydrolyses raft-sphingomyelin to ceramide.
Ceramide molecules spontaneously associate to form ceramide-enriched microdomains, which fuse to large ceramide-enriched membrane
platforms. The acid sphingomyelinase is activated by multiple stimuli including CD95, CD40, DR5/TRAIL, CD20, FcgRII, CD5, LFA-1, CD28,
TNF, the Interleukin-1 receptor, the PAF-receptor, CD14, infection with P. aeruginosa, S. aureus, N. gonorrhoeae, Sindbis-Virus, Rhinovirus,
treatment with g-irradiation, UV-light, doxorubicin, cisplatin, disruption of integrin-signaling and under some conditions of developmental death.
Ceramide-enriched membrane platforms serve the clustering of receptors, the recruitment of intracellular signaling molecules and the exclusion of
inhibitory signaling factors and, thus, facilitate signal transduction initiated by the specific stimulus.
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Singer and Nicolson suggested in 1972 the classical fluid
mosaic model of the cell membrane, which was based on the
finding that most physiological phospholipids exhibit low
melting temperatures and, therefore, most likely exist in a
liquid disordered phase [1]. However, many studies in the last
years modified this model and suggested that mammalian
membranes contain very small domains that are in a liquid-
ordered phase [2–6]. Biological membranes of eukaryotic cells
contain large amounts of sphingolipids and cholesterol in
addition to glycerophospholipids. Sphingolipids and choles-
terol predominantly localize to the outer leaflet of the cell
membrane. Sphingomyelin is the most prevalent membrane
sphingolipid and is composed of a hydrophobic ceramide
moiety and a hydrophilic phosphorylcholine headgroup.
Ceramide also forms the backbone of other complex
sphingolipids, e.g., cerebrosides and gangliosides. Ceramide
is composed of D-erythro-sphingosine and a fatty acid
containing 2–28 carbon atoms in the acyl chain. Most0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.09.001
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sphingosine base is connected with the acyl chain via an amide
ester bond. Ceramide is predominantly synthesized in the
endoplasmatic reticulum as is cholesterol, while the biosynthesis
of sphingomyelin occurs in the Golgi apparatus and to a lower
rate also in the plasma membrane [7–9]. The two pools of
sphingomyelin are connected by vesicular transport.
Sphingolipids, which have a much higher melting tempera-
ture than other phospholipids in the cell membrane, interact
with each other via hydrophilic interactions between the
sphingolipid headgroups [3–5]. These interactions are stabi-
lized by cholesterol that functions as a spacer between the bulky
sphingolipids and interacts with sphingolipids via hydrogen
bonds and hydrophobic van der Waal interactions of the sterol
ring system and the ceramide moiety of sphingolipids.
Cholesterol seems to fill the void spaces between bulky
sphingolipids [3–5]. The tight interaction between sphingoli-
pids and cholesterol results in a separation of sphingolipid- and
cholesterol-enriched membrane domains from other phospho-
lipids in the cell membrane. Interference with cholesterol
metabolism or extraction of cholesterol from rafts destroys
these membrane domains indicating the necessity of cholesterol
for the integrity of these structures. The formation of distinct1746 (2005) 284 – 294
http://www
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results in a lateral organization of the cell membrane. Since
these distinct domains seem to float in the membrane they were
named rafts [3]. Support for the existence of these domains was
deducted from the observation that the cell membrane contains
domains that are resistant to solubilization by non-ionic
detergents such as Triton X-100 at low temperatures [10]. It is
thought that the highly ordered spacial structure and the
composition of rafts result in a relative resistance of rafts to
detergents. These membrane domains were therefore also
termed detergent-insoluble glycolipid-enriched membranes
(DIGs) or detergent-resistant membranes (DRM). Atomic force
microscopy was employed to determine the size of rafts and
suggested an approximate diameter of rafts of 50 nm [11]. Many
studies made use of labeled cholera toxin that binds to GM1-
gangliosides enriched in membrane rafts to indirectly visualize
rafts [12].
Sphingomyelin is predominantly, maybe even exclusively,
present in the outer leaflet of the cell membrane. Accordingly,
rafts may exist in the outer leaflet of the cell membrane, while it
is unknown whether the inner leaflet of the cell membrane also
contains such distinct domains. It might be possible that the
higher organization of lipids in the outer leaflet and the long
side chains of ceramide alter the structure/composition of the
inner leaflet of the cell membrane and, thus translate the
suborganization of the outer membrane leaflet into rafts also to
the inner leaflet. It is also possible that unknown principles of
lipid organization in the inner leaflet of the cell membrane exist.
Finally, we would like to indicate that the existence of rafts
is still controversial [13], although many studies support the
idea of membrane rafts.
2. Ceramide-enriched membrane platforms
Many studies in the last years indicated that rafts are merged
into large membrane domains upon hydrolysis of sphingomye-Fig. 1. CD95 induces surface exposure of the acid sphingomyelinase. Jurkat T-lymph
anti-acid sphingomyelinase antibodies. The cells were then analyzed by scanning ele
The studies demonstrate that CD95-mediated stimulation of the cells results in a mark
permission of the JBC.)lin and generation of ceramide within rafts [14–29]. Initial
studies indicated that CD95 increases the catalytic activity Vmax
of the acid sphingomyelinase [30–32], which belongs to a
class of enzymes that hydrolyzes sphingomyelin and generates
ceramide. In addition to a stimulation of the acid sphingomye-
linase, CD95 also triggers a translocation of the enzyme onto
the extracellular leaflet of the cell membrane bringing the acid
sphingomyelinase into close vicinity to its substrate sphingo-
myelin [19,21] (Fig. 1). The translocation of the acid sphingo-
myelinase seems to be directed into rafts, since surface acid
sphingomyelinase co-localizes with fluorescent-labeled cholera
toxin [19], which is used as a marker for rafts. Activation and
translocation of the acid sphingomyelinase occurred very
rapidly after cellular stimulation and was observed within
10–30 s after stimulation via CD95 [19–21,25]. Ceramide
molecules dramatically change the biophysical properties of
rafts: Ceramide molecules spontaneously self-associate and
have the tendency to form small ceramide-enriched membrane
microdomains [33,34]. These microdomains are able to
spontaneously fuse to one or a few large ceramide-enriched
macrodomains, so called platforms [18,33,34] (Fig. 2). In
addition, the generation of ceramide within rafts permits very
tight packing of the lipids [34] and strongly stabilizes rafts [35].
Further, ceramide may alter the composition of pre-formed rafts
by the exclusion of cholesterol from rafts, which was shown in
biophysical studies on model membranes [36]. The formation of
ceramide-enriched membrane platforms was demonstrated in
fluorescence microscopy studies employing two different
antibodies against ceramide [21–29,37]. Furthermore, the local
treatment of a phosphatidylcholine/sphingomyelin-composed
unilamellar vesicle with sphingomyelinase that was immobi-
lized onto a microbead demonstrated rapid formation of large
ceramide-enriched domains in the membrane [18]. This
observation indicates that the formation of ceramide-enriched
membrane domains does not require cytoskeletal elements,
however, the study certainly does not exclude that ceramide-ocytes were stimulated for 2 min via CD95, fixed and stained with gold-coupled
ctron microscopy. The gold particles appear in the analysis as small white dots.
ed accumulation of the acid sphingomyelinase on the cell surface. (Printed with
Fig. 2. Ceramide-enriched membrane platforms facilitate signal transduction. Activation and surface-translocation of the acid sphingomyelinase result in the
generation of ceramide in the outer leaflet of the cell membrane. Surface ceramide forms large ceramide-enriched membrane platforms that serve the re-organization
and clustering of receptor molecules and/or the intracellular signalosom, an event that is required for cellular activation.
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vivo. Further magnetic resonance spectroscopy studies revealed
that incorporation of ceramide into model membranes results in
the formation of stable, distinct domains that correspond with a
transition of fluid phospholipid bilayers into a gel-like phase
[14]. This is consistent with the observation that small amounts
of ceramide significantly increase the gel-to-fluid transition
temperature of sphingomyelin and, thus, stabilize the liquid
ordered state [36]. Further experiments on model membranes
demonstrate spontaneous formation of ceramide-enriched
domains with as little as 5 mol% ceramide in the membrane
[15]. Finally, atomic force microscopy studies on artificial
membranes employing C16-ceramide, one of the most prevalent
natural ceramides, confirmed the laminar phase separation of
long chain ceramides in glycerophospholipid/cholesterol
bilayers [16].
In the recent years, a variety of studies supported this model
and demonstrated that many receptors or stimuli induce an
activation of the acid sphingomyelinase and/or a release of
ceramide and/or the formation of ceramide-enriched membrane
domains and/or require expression of the acid sphingomyeli-
nase for transmission of the specific biological effect. Those
receptors and stimuli include CD95 [19–21,30,31,38–40],
CD40 [23], DR5/TRAIL [41], CD20 [27], FcgRII [28], CD5
[42], LFA-1 [43], CD28 [44], TNF [45–47], the Interleukin-1
receptor [48], the PAF-receptor [49], CD14 [50], infection withFig. 3. P. aeruginosa induces the formation of ceramide-enriched membrane platfor
were fixed, isolated and stained with FITC-coupled anti-acid sphingomyelinase and C
ceramide-enriched membrane platform that contains the acid sphingomyelinase at tP. aeruginosa [24] (Fig. 3), S. aureus [51], N. gonorrhoeae
[52,53], Sindbis-Virus [54], Rhinovirus [55], g-irradiation
[56,57], UV-light [29,58,59], doxorubicin [60], cisplatin [26],
gemcitabine [61], disruption of integrin-signaling [62] and
some conditions of developmental death [59,63]. Although the
formation of ceramide-enriched membrane domains has not
been formally shown for all of those events (in fact for CD95,
CD40, DR5, CD20, FcgRII, P. aeruginosa, rhinoviruses, UV-
light, cisplatin and developmental death of neutrophils), these
data may suggest that ceramide-enriched membrane platforms
may function as a general motif in signaling transduction.
2.1. Function of ceramide-enriched membrane domains
In general, ceramide-enriched membrane platforms appear
to function as a tool that re-organizes receptor and signaling
molecules in and at the cell membrane to facilitate and amplify
signaling processes via a specific receptor. In this regard,
ceramide-enriched membrane domains do not seem to be part
of the specific signaling cascade of the activated receptor
molecule, allowing these membrane domains to have a general
function in many signaling pathways. The reorganization of
receptor molecules into ceramide-enriched membrane domains
may result in clustering of these receptor molecules and a very
high receptor density, which seems to be prerequisite for an
effective transmission of many signals into cells. A highms. Tracheal epithelial cells were infected in vivo with P. aeruginosa, the cells
y3-labeled anti-ceramide antibodies. The results demonstrate the formation of a
he bacterial infection site. (Printed with permission of Nat. Med.)
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activation of molecules that associate with the receptor.
Furthermore, ceramide-enriched membrane domains may serve
to recruit intracellular signaling molecules that transmit the
signal generated by receptor activation into the cell and/or
exclude molecules that negatively interfere with the signal
transduction pathway initiated by the receptor. The recruitment
of signaling molecules to the clustered receptor then enables
the receptor to successfully transmit the activation signal.
However, at present, it is unknown how ceramide-enriched
membrane domains in the outer leaflet of the cell membrane
are translated into changes of the protein composition of the
inner plasma membrane leaflet. Finally, clustering of a receptor
into rafts may stabilize the interaction with the receptor ligand
presented on a stimulatory cell, for instance in the immunologic
synapse. An increased ligand affinity might be also achieved
by a ceramide-mediated alteration of receptor conformation.
All of those events have been described for the CD95
receptor [25]: CD95 clusters in ceramide-enriched membrane
domains, which facilitates recruitment of the adapter protein
FADD, caspase 8 as well as caspase 3 to the aggregated CD95
receptor and transactivation of associated caspase 8 molecules
[25,64].
CD95 clustering, which may serve as a paradigm, is not
restricted to a single cell type and was recently demonstrated
by six independent groups to occur within seconds in Jurkat
cells, SKW 6.4 and JY B cell lymphoma, H9 T cell lymphoma,
epithelial and mouse granulosa cells, and in primary murine
spenocytes and hepatocytes [65]. The significance of CD95
clustering for the biological effects of this receptor was shown
in studies employing acid sphingomyelinase-deficient cells or
animals, respectively [19,20,25,39,40]. Acid sphingomyeli-
nase-deficient cells failed to release ceramide upon CD95
stimulation and resisted CD95-induced apoptosis [19,20].
Reconstitution of natural C16-ceramide to acid sphingomyeli-
nase-deficient cells restored the potential of CD95 to trigger
apoptosis, supporting the central role of ceramide for CD95-
triggered apoptosis. In vivo studies on acid sphingomyelinase-
deficient mice confirmed this notion and revealed that acid
sphingomyelinase-deficient hepatocytes were more than 10-fold
more resistant to induction of apoptosis after intravenous
injection of stimulatory anti-CD95 antibodies [39,40]. Very
similar data were obtained for TNF-receptor stimulation and
acid sphingomyelinase-deficient animals, which were protected
from TNF-a induced apoptosis of hepatocytes, hepatic failure
and death [46].
Consistent with the notion of an important role of membrane
domains for signaling of CD95 are experiments that revealed
an inhibition of CD95-induced apoptosis upon extraction of
cholesterol or neutralization of ceramide in ceramide-enriched
membrane domains using anti-ceramide antibodies
[19,37,66,67]. This finding was challenged by a study from
Algeciras-Schimnich et al. who failed to show a blockade of
apoptosis upon treatment with methyl-h-cyclodextrin [68].
However, it should be mentioned that efficient extraction of
cholesterol and destruction of rafts was not controlled and it
might be possible that a certain threshold of cholesterol-extraction must be reached to destroy rafts and prevent CD95-
induced apoptosis.
Although the above-described studies indicate a central role
of the acid sphingomyelinase for CD95-induced apoptosis, it
should be noted that some studies came to a different
conclusion for the function of the acid sphingomyelinase in
CD95- [69–71] or g-irradiation- [71] triggered apoptosis. A
study by Lin et al. [38] demonstrated that acid sphingomye-
linase-deficient hepatocytes and mice, respectively, are pro-
tected from CD95-induced apoptosis or death, while acid
sphingomyelinase-deficient and wildtype thymocytes or Con-
canavalin- or lipopolysaccharide-pre-stimulated lymphocytes
were equally sensitive to CD95-induced apoptosis.
How are ceramide-enriched membrane domains formed if
they are required for initiation of signaling for instance via
CD95? This hen-and-egg problem is best illustrated by
experiments on the ordering of signaling events initiated by
CD95 [25]. Ligand binding and cross-linking of CD95 trimers
results in a very weak recruitment of FADD and stimulation of
caspase 8, which reaches approximately 1% of the levels that
are observed for maximal activation of caspase 8. This weak
activation of caspase 8 is even observed in acid sphingomye-
linase-deficient cells, but it is not sufficient to trigger apoptosis.
However, the low activity of caspase 8 is sufficient to trigger
the translocation and activation of the acid sphingomyelinase
and the formation of ceramide-enriched membrane platforms.
In a feed-forward mechanism, these domains then cluster
dispersed CD95 molecules and permit efficient recruitment and
full activation of caspase 8 to execute death. These studies
indicated that clustering of CD95 in ceramide-enriched
membrane domains mediates an approximately 100-fold
amplification of the signal intensity of the receptor. Very
similar findings were recently observed for the DR5/TRAIL
system [41].
Many studies demonstrated that a function of ceramide-
enriched membrane platforms is not restricted to receptor-
mediated signaling. It was shown that g-irradiation [56,57],
UV-A and UV-C light [29,58,59], some chemotherapeutics
[26,27,60] and bacterial as well as viral infections [51–54]
require the acid sphingomyelinase to trigger apoptosis. The
significance of the acid sphingomyelinase and ceramide
system for the biological effects of stress was best investigated
for g-irradiation, which may serve as a paradigm for the
function of the acid sphingomyelinase and ceramide in the
cellular stress response. Acid sphingomyelinase-deficient T- and
B-lymphocytes [56] and murine embryonic fibroblasts [72]
failed to release ceramide upon g-irradiation. Moreover, these
cells as well as acid sphingomyelinase-deficient oocytes [60,73]
and endothelial cells [57] were resistant to g-irradiation-induced
cell death. Likewise, acid sphingomyelinase-deficient mice were
protected from radiation-induced ceramide formation and
damage in the lung [56], small intestine [57] or brain [74],
while radiation-induced cell death was readily observed in
normal mice. g-irradiation of the gastrointestinal tract and the
central nervous system primarily targeted endothelial cells and
killed those cells via an activation of the acid sphingomyelinase
[51,74], while endothelial cells lacking the acid sphingomyeli-
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thelial cell apoptosis leads to vascular dysfunction and the
gastrointestinal (GI)-syndrome characterized by loss of the
water barrier resulting in diarrhoea and dehydration, and loss of
the barrier for enterobacteria predisposing to sepsis. According-
ly, acid sphingomyelinase-deficient mice were protected from
the development of a GI-syndrome upon radiation, while
wildtype mice developed a severe GI-syndrome and died.
A very similar phenomenon was observed for the
irradiation of tumors: Tumors that were implanted into acid
sphingomyelinase-deficient mice were resistant to g-irradia-
tion, although the same tumors implanted into wildtype mice
were radiosensitive [75]. These studies by R. Kolesnick and
Z. Fuks revealed that g-irradiation triggered apoptosis of
wildtype endothelial cells, while acid sphingomyelinase-
deficient endothelial cells of the tumor vessels were resistant
to irradiation-induced apoptosis resulting in resistance of the
tumor to radiation [75]. These data prove a central role of the
acid sphingomyelinase in g-irradiation-induced cell death.
However, formally it remains to be determined whether
ceramide-enriched membrane platforms mediate the effects
of g-irradiation.
3. Mechanisms of acid sphingomyelinase activation and
surface translocation
At present, the molecular mechanisms mediating surface
translocation and activation of the acid sphingomyelinase are
not well understood. CD95 has been shown to trigger
translocation and activation of the acid sphingomyelinase via
a recruitment of an adaptor protein, FADD, and activation of a
protease, caspase 8 [25,76]. The association of CD95 with
FADD and caspase 8 is mediated by a short intracellular
domain, the death domain [77,78]. Accordingly, mutation of
the death domain and genetic or pharmacological inhibition,
respectively, of caspase 8 prevented activation of the acid
sphingomyelinase [76,79]. Vice versa, overexpression of
FADD or caspase 8, or transfection of a constitutively active
caspase 8 mutant resulted in increased ceramide release [80]. In
contrast, activation of the acid sphingomyelinase by TNF-R
does not seem to be mediated by caspase 8 and an unknown
initiator caspase was suggested to function between the
receptor and the acid sphingomyelinase [81]. However, since
caspases are cytosolic enzymes and the acid sphingomyelinase
localizes to abluminal compartments, i.e., vesicles or the outer
leaflet of the cell membrane, it seems to be unlikely that
caspases directly activate the acid sphingomyelinase, e.g.
through limited proteolysis. A recent study employing cells
treated with z-VAD or deficient for caspase 8 or FADD,
respectively, also demonstrated that activation of capases is
required for acid sphingomyelinase-mediated release of cer-
amide and the formation of ceramide-enriched membrane
platforms upon stimulation via CD95, while UV-C light
induced these events independent of caspase-activity [59].
These data suggest that several pathways exist to induce an
activation of the acid sphingomyelinase and the formation of
ceramide-enriched membrane domains.Further studies indicated an association of the acid
sphingomyelinase with phosphatidylinositol-3-kinase (PI-3-K)
upon nerve growth factor stimulation of PC12 cells via TrkA
[82]. These authors suggested a direct interaction of the acid
sphingomyelinase with the regulatory p85 subunit of PI-3-K
within rafts. Nerve growth factor-mediated activation of PI-3-K
resulted in an approximately 50% inhibition of the activity of
the acid sphingomyelinase suggesting that phosphatidyl-inosi-
tol-phosphates negatively regulate the acid sphingomyelinase.
However, the interaction of the two proteins is difficult to
reconcile on the background of the abluminal localization of
the acid sphingomyelinase and a cytoplasmic presence of PI-3-
K. It might be possible that the acid sphingomyelinase folds
into the cell membrane and, thus, might be able to interact with
intracellular proteins or lipids, although the acid sphingomye-
linase is not known to contain an obvious transmembranous
domain.
Several recent studies also demonstrated an inhibition of the
acid sphingomyelinase by inositol-phosphates [83,84]. How-
ever, the physiological significance of these findings remains to
be determined since inhibition of the acid sphingomyelinase
required very high phosphate concentrations.
Finally, a study by Qui et al. [85] demonstrated that in vitro
oxidation of the cysteine residue 629 of the acid sphingomye-
linase molecule results in constitutive activation of the enzyme.
Likewise, a copper-promoted dimerization of the acid sphingo-
myelinase via this cysteine residue stimulated the enzyme’s
activity. Since many stress stimuli induce the formation of
oxygen radicals, an oxidation of the acid sphingomyelinase
might also activate the enzyme in vitro, although this
mechanism has to be proven in vivo.
The enzyme activity of the acid sphingomyelinase reaches
an optimum at an acidic pH suggesting that the enzyme should
be only active in the lysosome. However, only the substrate
affinity is affected by neutral pH values, which increase the Km
value, but do not alter the activity [Vmax] of the enzyme [86].
Since many factors including membrane lipids such as
cholesterol or LDL have been shown to modify the activity
of the acid sphingomyelinase, it is very likely that full activity
of the enzyme on the cell surface is achieved even at neutral pH
values [87]. For instance a Bacillus cereus sphingomyelinase is
almost inactive on large unilamellar vesicles without choles-
terol [88]. Small quantities of cholesterol slightly increased the
enzyme’s activity, while an increase of the cholesterol
concentration above 25 mol% resulted in a remarkable
enhancement of the activity of the enzyme. This finding might
also explain why interference of nystatin, filipin or h-methylcy-
clodextrin with cellular cholesterol prevents the hydrolysis of
sphingomyelin by the acid sphingomyelinase.
4. Mechanisms of receptor clustering in ceramide-enriched
membrane domains
Although receptor clustering is a general and fundamental
mechanism of signal transduction into cells, the molecular and
structural mechanisms of the preferred partitioning of a
receptor in membrane domains are poorly characterized.
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instance GPI-linked proteins, might cluster simply by the
fusion of small ceramide-enriched microdomains to a large
ceramide-enriched membrane domain.
The situation is much more complex for receptors that
primarily reside outside of rafts. Studies from our laboratory
indicate a central function of the transmembranous domain
of CD40 for trapping and localization of CD40 in ceramide-
enriched membrane domains [22]. These studies employed
chimeric proteins that consisted of the extra- and intracellular
domain of CD40 and the transmembranous domain of CD45.
CD45 is known to localize outside of rafts, at least under
most circumstances. These studies revealed that wildtype
CD40 translocates and becomes trapped in ceramide-enriched
membrane domains after stimulation, while a chimeric
protein consisting of the transmembranous domain of
CD45 did not localize into ceramide-enriched membrane
domains. This correlated with a failure of the mutant protein
to cluster and to signal into the cell upon stimulation under
physiological conditions. However, forced, artificial cluster-
ing of the CD40/CD45 chimeric protein resulted in
activation of JNK, which is a known target of CD40
[89,90], indicating that the exchange of the transmembranous
domain did not inactivate the mutant protein. It further
emphasizes the importance of receptor clustering for cellular
activation under physiological conditions. At present, it is
unknown how the transmembranous domain initiates trap-
ping of receptor molecules in ceramide-enriched membrane
domains. Binding of the ligand might change the conforma-
tion of the transmembranous domain of the cognate receptor
and might promote direct interaction of the transmembranous
domain with ceramide. However, it also seems to be possible
that the formation of ceramide-enriched membrane domains
alters the diameter of the cell membrane in this domain.
Therefore, the number of hydrophobic amino acids in the
transmembranous domain of a receptor may determine
whether trapping of a transmembranous protein in cera-
mide-enriched membrane domains occurs or whether the
presence of the protein outside of these domains is
energetically more favorable.
5. Regulation of protein function by ceramide-enriched
membrane domains
Ceramide generated by the acid sphingomyelinase in the
outer leaflet of the cell membrane or within intracellular
vesicles may also flip to the cytoplasmic leaflet, although
the mechanisms of flipase-like translocation of ceramide
from one membrane to another membrane leaflet are
unknown. Intracellular ceramide has been described to
interact and activate phospholipase A2 [91], kinase suppres-
sor of Ras (KSR; identical to ceramide-activated protein
kinase) [92], ceramide-activated protein serine-threonine
phosphatases [93], protein kinase C isoforms [94] and c-Raf-1
[95]. Further, intravesicular ceramide was demonstrated to bind
cathepsin D [96]. Ceramide may bind directly to PLA2 [91] and
cathepsin D [96], while the exact mechanism of ceramide-mediated regulation of most of the above proteins is still
unknown. The interaction of ceramide with cathepsin D has been
matched to a short domain in cathepsin D, which triggers the
autocatalytic cleavage of cathepsin D to its active form and
seems to promote the translocation of the enzyme from
endosomes into the cytoplasm [96,97]. Whether these proteins
interact with individual ceramide molecules or with the
hydrophobic platform of a ceramide-enriched membrane
domain remains to be investigated.
In addition, ceramide-enriched membrane platforms are
involved in the regulation of ion channels, in particular the
Kv1.3 channel and calcium release activated calcium
(CRAC) channels [98–101]. Kv1.3 channels are central for
the activation, differentiation, proliferation and regulation of
apoptosis in lymphocytes [102,103]. Recent studies indicated
that the potassium channel Kv1.3 is constitutively present in
membrane rafts and localizes to ceramide-enriched mem-
brane domains after stimulation via CD95 [22]. Translocation
of the channel protein into ceramide-enriched membrane
domains correlates with an inactivation of the Kv1.3 channel
[22]. Likewise, disruption of rafts by cholesterol-extracting
drugs inhibits Kv1.3. Ceramide-enriched membrane domains
may serve to recruit intracellular signaling molecules, in
particular Src-like tyrosine kinases, that inhibit the activity of
Kv1.3 [104]. Vice versa, rafts may separate the channel from
Src-like tyrosine kinases and, thus, enable the channel to
remain in its active status. Therefore, the sorting function of
ceramide-enriched membrane platforms may bring the
channel into close vicinity to its regulators and permits,
for instance, inhibition of Kv1.3 by tyrosine phosphorylation
of the protein within ceramide-enriched membrane domains.
However, the alteration of the lipid composition in ceramide-
enriched membrane domains may also have a direct effect on
the activity of the channel. This concept is supported by
data from D. Oliver et al. who demonstrated a regulation of
A-type potassium channels by membrane lipids, in partic-
ular phosphoinositides and arachidonic acid [105]. It could
be envisioned that ceramide-enriched membrane domains
alter the conformation of Kv1.3 resulting in an inactivation
of the channel, while intact rafts promote a conformation
that permits channel activity. Alteration of rafts by
sphingomyelin hydrolysis and ceramide generation or
destruction of rafts by cholesterol-extraction may then
inhibit the channel.
Similar effects were described for CRAC channels. CRAC
channels are central in the regulation of cellular Ca2+
concentrations and, thus, involved in multiple cellular path-
ways [106]. Stimulation of cells via CD95 [100,107] or the
TNF-receptor [101] results in inhibition of CRAC channels,
which is dependent on expression of the acid sphingomyeli-
nase. Furthermore, synthetic ceramides, C2-, C6- and C16-
ceramides, inhibit the activity of CRAC channels. Endogenous
ceramide and long chain ceramides may inhibit CRAC
channels by the transformation of rafts into ceramide-enriched
membrane domains as discussed for Kv1.3, while incorpora-
tion of short chain ceramides may interfere with the integrity of
rafts.
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Several recent studies indicate that ceramide is also
present in mitochondria [108–111]. Mitochondrial ceramide
could be generated via the de novo synthesis pathway, a
reverse activity of the ceramidase [112] and activity of the
acid sphingomyelinase, which has been shown to reside in
the space between the inner and outer mitochondrial
membrane [113]. At present, only the de novo pathway
and the acid sphingomyelinase have been implied in
mitochondrial ceramide generation. Mitochondrial ceramide
has been suggested to be involved in apoptosis [109],
however, the mechanisms how mitochondrial ceramide
mediates apoptosis remain to be defined. It is possible that
mitochondrial ceramide also forms ceramide-enriched mem-
brane domains that serve the re-organization of proteins
involved in apoptosis. Furthermore, it has been described that
C16-ceramide is able to form large channels [114], which
may permit the exit of cytochrome c from mitochondria upon
induction of apoptosis.
7. Infections via ceramide-enriched membrane platforms
Rafts have been shown to serve many pathogens for
infection of cells including several bacteria such as Escherichia
coli, Mycobacterium tuberculosis, Campylobacter jejuni,
Vibrio cholerae, Clostridium difficile, Clostridium tetani,
Salmonella typhi and typhimurium, Shigella flexneri, some
viruses such as Inflenza virus, HIV, Measles virus, Respiratory
syncytial virus, Ebolavirus, Papillomaviridae, EBV, Echovirus,
Sindbis virus, various parasites such as Plasmodium falci-
parum, Trypanosoma, Leishmania and Toxoplasma gondii and
even Prions (for recent reviews see [115,116]). However, at
present it is unknown whether all these pathogens employ
membrane platforms for infection of the cells or whether
unmodified small sphingolipid- and cholesterol-enriched mem-
brane rafts are sufficient to transmit the infection. Our studies
indicate that at least some bacteria and viruses modify rafts into
ceramide-enriched membrane platforms. We demonstrated that
Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus
aureus (S. aureus), Neisseriae gonorrhoeae (N. gonorrhoeae)
and Rhinovirus use the acid sphingomyelinase for the
generation of ceramide and ceramide-enriched membrane
platforms that serve the infection of the mammalian target
cells [24,51–53,55].
These pathogens activated the acid sphingomyelinase and
induced a translocation of the enzyme onto the cell surface
within minutes after tethering and adhering to the cell, which
resulted in the release of ceramide and the formation of large
ceramide-enriched membrane platforms in epithelial cells,
fibroblasts and endothelial cells. Genetic deficiency or phar-
macological inhibition of the acid sphingomyelinase prevented
the release of ceramide and subsequent internalization of P.
aeruginosa, S. aureus, N. gonorrhoeae as well as induction of
apoptosis of the host cells by P. aeruginosa or S. aureus
[24,51–53]. Furthermore, infection of epithelial cells with P.
aeruginosa resulted in a release of pro-inflammatory media-tors, which was significantly increased in cells lacking the acid
sphingomyelinase.
In vivo studies with P. aeruginosa confirmed a central role
in vivo of the acid sphingomyelinase for pulmonary P.
aeruginosa infections [24]. While normal mice were able to
clear a pulmonary P. aeruginosa infection, acid sphingomye-
linase-deficient mice were unable to eliminate the bacteria,
bronchial epithelial cells failed to undergo apoptosis and to
internalize the bacteria and the mice responded with a massive
release of cytokines in the lung. The mice finally died by
sepsis.
P. aeruginosa induces the clustering of CD95 and the cystic
fibrosis transmembrane conductance regulator (CFTR) in
ceramide-enriched membrane domains [24]. We and others
demonstrated that P. aeruginosa-induced apoptosis is mediated
by CD95 activation [117–119] and, thus, clustering of CD95 in
ceramide-enriched domains is very likely the initial event for
triggering apoptosis of the host cell. Mechanisms that mediate
the internalization of P. aeruginosa are much less character-
ized. It was suggested that CFTR functions as a receptor for
P. aeruginosa and mediates internalization of the bacteria
[120,121]. However, even P. aeruginosa strains that do not
interact with CFTR are internalized and, thus, additional
receptors may exist that mediate internalization [121]. Thus,
clustering of CFTR might initiate P. aeruginosa internalization
in some cases, but additional mechanisms that are also
dependent on ceramide-enriched membrane domains seem to
be operative in parallel. Finally, at present, it is unknown how
ceramide-enriched membrane domains regulate the release of
pro-inflammatory mediators such as Interleukin-1 upon infec-
tion with pathogens.
In summary, although some receptors that cluster in
ceramide-enriched membrane domains upon infection of
mammalian cells have been identified [24], the mechanism
how ceramide-enriched membrane domains mediate the
infection of mammalian cells require further definition.
Further studies indicated that the acid sphingomyelinase and
ceramide-enriched membrane platforms are also involved in
viral infections of mammalian cells. Data from our group [55]
reveal that rhinoviruses very rapidly activated the acid
sphingomyelinase, triggered a release of ceramide and induced
the formation of large ceramide-enriched membrane platforms.
Genetic or pharmacological inhibition of the acid sphingomye-
linase prevented rhinoviral infection of human epithelial cells.
Furthermore, it was demonstrated that Sindbis virus activated
the acid sphingomyelinase and mediated the release of
ceramide, which was required for the induction of apoptosis
in infected cells by this virus [54].
Recent studies discovered a novel function of the acid
sphingomyelinase and ceramide in the signaling of platelet
activating factor (PAF) and pulmonary failure caused by PAF
[49,122]. PAF, one of the most important mediators of septic
shock and multi-organ failure, very rapidly activated the acid
sphingomyelinase and triggered a release of ceramide in the
lung. Intravenous injection of PAF induced pulmonary edema,
which was significantly reduced in acid sphingomyelinase-
deficient mice. Combined inhibition of the acid sphingomye-
C.R. Bollinger et al. / Biochimica et Biophysica Acta 1746 (2005) 284–294 291linase and the cycloxygenase, which is also activated by PAF,
completely prevented pulmonary edema. PAF was also
demonstrated to induce externalization of phosphatidylserine
on the surface of erythrocytes, which resulted in a pre-mature
deletion of erythrocytes from the blood [122]. Inhibition of the
acid sphingomyelinase prevented these events elicited by PAF.
Therefore, it seems likely that further systemic events in
patients with sepsis are mediated by the acid sphingomyelinase
and ceramide.
Finally, recent studies on the maturation of phagosomes
suggest that sphingolipids and ceramide are involved in the
intracellular processing of vesicles. Internalization of bacteria
into mammalian cells results in the formation of vesicles, so
called endosomes. Endosomes are transported in the cell,
mature and fuse with lysosomes to form a phagolysosome,
which are central for the degradation of the bacteria. The fusion
of the two vesicles requires the coordinated assembly of actin
filaments on phagosomes. Studies by Anes et al. [123]
demonstrated that this fusion process is regulated by sphingo-
lipids including ceramide that seem to serve as a binding and
nucleation site for the interaction of actin with phagosomes.
7.1. Perspectives
The comprehensive concept of ceramide-enriched mem-
brane domains and the ceramide-mediated transformation of
very small ‘‘inactive’’ membrane rafts into large, ‘‘active’’
signaling platforms explains the function of ceramide for
cellular activation by many and diverse receptors, stress stimuli
and even developmental processes. Ceramide does not seem to
play a specific role in many of these signaling pathways, but re-
organizes receptor molecules and the signalosom in the cell and
is a pre-requisite for signal transduction by the above-discussed
pathways. The important role of ceramide and ceramide-
enriched membrane platforms, respectively, in cellular signal
transduction, suggest that a pharmacological manipulation of
these membrane domains might be useful to treat at least some
forms of cancer, infectious diseases or chronic degenerative
disorders.
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